| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2024―Mrz―06 |
In Silico Evaluation of NO-Sartans against SARS-CoV-2 |
Negar Omidkhah, Farzin Hadizadeh, Razieh Ghodsi, Prashant Kesharwani, Amirhossein Sahebkar |
| 2 |
[GO] |
2023―Dez―27 |
In Silico Screening of Some Active Phytochemicals to Identify Promising Inhibitors Against SARS-CoV-2 Targets |
V. Alagarsamy, V. Raja Solomon, S. Murugesan, P. Shyam Sundar, MD. Muzaffar-Ur-Rehman, Ala Chandu, A. Dharshini Aishwarya, B. Narendhar, M. T. Sulthana, V. Ravikumar |
| 3 |
[GO] |
2023―Apr―20 |
The Open, Randomized, Positive Control Clinical Trial of Guluronic Acid (G2013) on SARS-CoV-2 Patients |
Abbas Mirshafiey, Zahra Aghazadeh, Davod Sanaee Delir, Hamid Reza Gholamrezaie, Arezoo Sadoughi, Amir Nezami Asl, Mehran Noori Sanami, Armita Mahdavi Gorabi, Younes Panahi, Mahsa Taeb, Alireza Razavi, Sara Rafia, Zahra Naderiyan, Behrouz Robat-Jazi |
| 4 |
[GO] |
2022―Okt―20 |
Hesperidin: A Potential Therapeutic agent against COVID-19 |
Ashwani K. Dhingra, Bhawna Chopra, Vaibhav Rathi, Sameer Sapra |
| 5 |
[GO] |
2022―Okt―12 |
In silico analysis of the antidepressant fluoxetine and related drugs at SARS-CoV-2 main protease (Mpro) and papain-like protease (PLpro) |
João Batista Teixeira Rocha, Pedro José Tronco Pauletto, Folorunsho Bright Omage, Cássia Pereira Delgado, Pablo Andrei Nogara |
| 6 |
[GO] |
2022―Sep―12 |
In-silico designing of a multi-epitope vaccine against SARS-CoV2 and studying the interaction of the vaccine with Alpha, Beta, Delta, and Omicron variants of concern |
Santanu Paul, Aranya Pal, Nibedita Pyne |
| 7 |
[GO] |
2022―Jan―28 |
Structure-Based Drug Design and Development of Novel Synthetic Compounds with Anti-Viral Property against SARS-COV-2 |
Reshma Tendulkar, Aasma Chouhan, Avika Gupta, Aaliya Chaudhary, Chandani Dubey, Sushil Shukla |
| 8 |
[GO] |
2022―Jan―18 |
Computational Approach to Combat COVID-19 Infection: Emerging Tool for Accelerating Drug Research |
Biswa Mohan Sahoo, Subrat Kumar Bhattamisra, Sarita Das, Abhishek Tiwari, Varsha Tiwari, Manish Kumar, Sunil Singh |
| 9 |
[GO] |
2020―Dez―29 |
ACE2 as a potential target for management of novel coronavirus (nCoV- 2019) |
Elham Foroozanfar, Mohamad Forouzanfar, Tahereh Farkhondeh, Saeed Samarghandian, Fatemeh Forouzanfar |
| 10 |
[GO] |
2020―Sep―26 |
Identification of Main Protease of Coronavirus SARS-CoV-2 (Mpro)Inhibitors from Melissa officinalis |
Olusola O. Elekofehinti, Opeyemi Iwaloye, Courage D. Famusiwa, Olanrewaju Akinseye, Joao B. T. Rocha |
| 11 |
[GO] |
2020―Aug―26 |
COVID-19 Infection and Vitamin D: Current Scenario and Future Prospect |
Leila Peivasteh-Roudsari, Behrouz Tajdar-Oranj, Parisa Sadighara |
|
